Safety, tolerability and immunogenicity of Biological E’s CORBEVAX™ vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 study
Subhash Thuluva, Vikram Paradkar, SubbaReddy Gunneri, Vijay Yerroju, Rammohan Reddy Mogulla, Pothakamuri Venkata Suneetha, Kishore Turaga, Mahesh Kyasani, Senthil Kumar Manoharan, Srikanth Adabala, Aditya Sri Javvadi, Guruprasad R. Medigeshi, Janmejay Singh, Heena Shaman, Akshay Binayke, Aymaan Zaheer, Amit Awasthi, Manish Narang, Pradeep Nanjappa, Niranjana Mahantshetti, Bishan Swarup Garg, Anil Kumar Pandey
Topics & Concepts
TolerabilityImmunogenicityReactogenicityMedicinePlaceboAdverse effectInternal medicinePopulationRandomizationImmunologyRandomized controlled trialPediatricsImmune systemPathologyEnvironmental healthAlternative medicineViral Infections and Immunology ResearchSARS-CoV-2 and COVID-19 ResearchMultiple Sclerosis Research Studies